These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 38790958)

  • 1. Analysis of Cultured Gut Microbiota Using MALDI-TOF MS in COVID-19 Patients from Serbia during the Predominance of the SARS-CoV-2 Omicron Variant.
    Patić A; Kovačević G; Vuković V; Hrnjaković Cvjetković I; Ristić M; Milosavljević B; Medić D; Djilas M; Radovanov J; Kovačević A; Pustahija T; Balać D; Petrović V
    Microorganisms; 2024 Aug; 12(9):. PubMed ID: 39338474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAFLD/MASLD and the Gut-Liver Axis: From Pathogenesis to Treatment Options.
    Vallianou NG; Kounatidis D; Psallida S; Vythoulkas-Biotis N; Adamou A; Zachariadou T; Kargioti S; Karampela I; Dalamaga M
    Metabolites; 2024 Jun; 14(7):. PubMed ID: 39057689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
    Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial Signatures in COVID-19: Distinguishing Mild and Severe Disease via Gut Microbiota.
    Galeeva JS; Fedorov DE; Starikova EV; Manolov AI; Pavlenko AV; Selezneva OV; Klimina KM; Veselovsky VA; Morozov MD; Yanushevich OO; Krikheli NI; Levchenko OV; Andreev DN; Sokolov FS; Fomenko AK; Devkota MK; Andreev NG; Zaborovskiy AV; Bely PA; Tsaregorodtsev SV; Evdokimov VV; Maev IV; Govorun VM; Ilina EN
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38790958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.
    Romani L; Del Chierico F; Macari G; Pane S; Ristori MV; Guarrasi V; Gardini S; Pascucci GR; Cotugno N; Perno CF; Rossi P; Villani A; Bernardi S; Campana A; Palma P; Putignani L;
    Front Cell Infect Microbiol; 2022; 12():908492. PubMed ID: 35873161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.
    Reinold J; Farahpour F; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Hoffmann D; Buer J; Witzke O; Westendorf AM; Kehrmann J
    Front Cell Infect Microbiol; 2021; 11():747816. PubMed ID: 34869058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity.
    Maeda Y; Motooka D; Kawasaki T; Oki H; Noda Y; Adachi Y; Niitsu T; Okamoto S; Tanaka K; Fukushima K; Amiya S; Hara R; Oguro-Igashira E; Matsuki T; Hirata H; Takeda Y; Kida H; Kumanogoh A; Nakamura S; Takeda K
    BMC Infect Dis; 2022 Jun; 22(1):572. PubMed ID: 35751044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An adaptive ensemble deep learning framework for reliable detection of pandemic patients.
    Iqbal MS; Naqvi RA; Alizadehsani R; Hussain S; Moqurrab SA; Lee SW
    Comput Biol Med; 2024 Jan; 168():107836. PubMed ID: 38086139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions.
    Chen J; Siliceo SL; Ni Y; Nielsen HB; Xu A; Panagiotou G
    Microbiome; 2023 Aug; 11(1):178. PubMed ID: 37553697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Overview of the Factors Involved in Biofilm Production by the
    Șchiopu P; Toc DA; Colosi IA; Costache C; Ruospo G; Berar G; Gălbău ȘG; Ghilea AC; Botan A; Pană AG; Neculicioiu VS; Todea DA
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511337
    [No Abstract]   [Full Text] [Related]  

  • 12. Gut microbiota Turicibacter strains differentially modify bile acids and host lipids.
    Lynch JB; Gonzalez EL; Choy K; Faull KF; Jewell T; Arellano A; Liang J; Yu KB; Paramo J; Hsiao EY
    Nat Commun; 2023 Jun; 14(1):3669. PubMed ID: 37339963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the gut microbiome associated with COVID-19.
    Maddah R; Goodarzi V; Asadi-Yousefabad SL; Abbasluo M; Shariati P; Shafiei Kafraj A
    Inform Med Unlocked; 2023; 38():101239. PubMed ID: 37033411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term gastrointestinal outcomes of COVID-19.
    Xu E; Xie Y; Al-Aly Z
    Nat Commun; 2023 Mar; 14(1):983. PubMed ID: 36882400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in Gut Microbiota Composition in Patients with COVID-19: A Pilot Study of Whole Hypervariable 16S rRNA Gene Sequencing.
    Mańkowska-Wierzbicka D; Zuraszek J; Wierzbicka A; Gabryel M; Mahadea D; Baturo A; Zakerska-Banaszak O; Slomski R; Skrzypczak-Zielinska M; Dobrowolska A
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830905
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.